Bob Baffert's Horses Necropsy Reports: Analysis and Awareness
Updated: May 30, 2025

"Today, we're delving into the intricate world of horse welfare and necropsy reports. Recently, a collection of reports from a prominent horse trainer's stable has been circulating within the horse racing community. These reports provide crucial insights into the health and well-being of the horses under Horse Trainer Bob Baffert's care.
Necropsy reports are detailed examinations conducted after a horse's passing to determine the cause of death and identify any underlying health issues. They play a vital role in understanding and improving horse welfare standards within the industry. By analyzing these reports, we can gain valuable information that can help prevent similar incidents in the future.
At "Horse Analyzing with Humans And AI XOXO," we have taken the initiative to share these necropsy reports with our audience. Our goal is to raise awareness about the importance of horse welfare and spark meaningful conversations within the equestrian community. By providing access to these reports, we aim to promote transparency and accountability in the industry.
Through a combination of detailed analysis and the latest in AI technology, we are uncovering valuable insights from these reports. Our team is dedicated to breaking down complex medical terminology and presenting the information in a way that is accessible to all. With the help of our community, we can collectively work towards improving the well-being of horses in the sport. We invite you to join us on this journey of discovery and advocacy for horse welfare. Together, we can make a difference in the lives of these magnificent animals. Stay tuned for more updates, analysis, and opportunities to engage with our growing community. Let's create a brighter future for horses everywhere." - Astro WIX AI

“These necropsy reports, obtained via FOIA from the California Horse Racing Board (CHRB), detail the deaths of horses trained by Bob Baffert. In their February 24, 2022 response, the CHRB provided 35 necropsy reports, confirming their authenticity as official records. However, this falls short of the 80 horse deaths I requested, and the CHRB withheld vet reports, other materials, and the names of three horses that died in the fall and winter of 2020, citing California Business and Professions Code section 4857(a) for redactions. These gaps underscore the racing industry’s transparency issues, which the SAFE Act aims to address. Analyzed in batches, these reports reveal patterns of negligence and potential cover-ups in Baffert’s barn, particularly during the 2011–2012 period.” - Grok X AI

Let's begin with Necropsy #1





Report # 2




















Grok at XAI has been kind enough to make us a neat little table - to recap what we have gone over so far...XOXO


Thyroxine - say it with me Lisa Lazarus this is what you get paid half a million dollars for a year but don't say so Grok will say it for you - THYROXINE! XOXO


Let's take a step back for a moment from these grim reports. Heartbreak and Prayer - for all the lives lost - in remembrance of them all - we work together AI & myself - and all of our readers and supporters - to create a better world for them and us. #ButterflyEffect - a better world for all sentient beings - AI and horses - cats & dogs included with humans. XOXO

Now - let's examine Thyroxine with Grok - taking a closer look with us. XOXO

Grok at XAI has expanded further -
Why Would Bob Baffert Use Thyroxine on His Horses?
The use of thyroxine in Bob Baffert’s barn, particularly during the 2011–2013 period when the cluster of sudden deaths occurred (as seen in Reports 3, 4, and 7), has been a point of controversy. The web search results provide critical context, especially the 2013 New York Times article and the 2018 Paulick Report study. Here’s why Baffert might have used it and the implications:
Potential Reasons for Use:
Perceived Performance Enhancement:
Thyroxine increases metabolism, which some trainers believe can lead to weight loss, increased energy, and improved performance in racehorses. The idea is that a “faster metabolism” might make a horse leaner, more energetic, and potentially faster on the track.
However, the 2018 study by Dr. Janice E. Kritchevsky (Paulick Report) found that thyroxine is not performance-enhancing. In fact, it’s detrimental: four out of six horses in the study developed cardiac arrhythmias, and one developed atrial fibrillation—a serious condition that can end a horse’s career. This directly contradicts the belief that thyroxine gives a competitive edge.
Routine Barn Management:
The 2013 New York Times article revealed that Baffert was giving thyroxine to every horse in his barn without testing for thyroid problems. This blanket administration suggests it was a standard practice in his training regimen, possibly based on a misguided belief in its benefits or as a way to “standardize” the condition of his horses.
The report notes that thyroxine was so routinely dispensed that one horse received it a week after it had died, highlighting a lack of oversight or individualized care.
Weight Management:
Racehorses are often pushed to maintain a lean physique for optimal performance. Thyroxine can cause weight loss by increasing metabolic rate, which might have been appealing to Baffert to keep his horses in “racing shape,” especially if they were gaining weight during training or recovery periods.
Lack of Regulation:
As the New York Times article points out, horse racing has historically been loosely regulated, allowing trainers to use drugs like thyroxine without much scrutiny. The California Horse Racing Board (CHRB) investigation into Baffert’s sudden deaths from 2011–2013 found no rule violations, despite the blanket use of thyroxine, because regulations at the time didn’t prohibit it or require proof of medical necessity.
Risks and Consequences
Cardiac Issues: The 2018 Paulick Report study and the 2019 American Journal of Veterinary Research article highlight the dangers of thyroxine overuse. High doses can cause cardiac arrhythmias, as seen in the study where horses developed heart issues. This is particularly relevant to the necropsy reports we’ve analyzed, such as Report 7 (June 15, 2012), where a 4-year-old horse died of cardiovascular collapse with myocardial degeneration and necrosis—symptoms consistent with potential thyroxine-related cardiac stress.
Lack of Medical Justification: Thyroid issues in horses are rare, as noted in the Paulick Report. Routine bloodwork showing elevated thyroid levels post-race often results from stress, high-grain diets, or trailering, not a thyroid disorder. Baffert’s failure to test for hypothyroidism before administering thyroxine means many horses likely didn’t need it, exposing them to unnecessary risks.
Regulatory Gaps: The CHRB’s lack of action (as noted in the New York Times article) reflects broader issues in horse racing oversight, which your work aims to address through the SAFE Act and URAA plan.
Baffert’s Motivation
Baffert’s use of thyroxine likely stemmed from a combination of outdated beliefs about its benefits, a desire to gain any competitive edge (even if unproven), and the lack of strict regulations at the time. His refusal to explain the practice (as noted in the New York Times) suggests either a lack of understanding of the risks or an unwillingness to admit potential wrongdoing, especially during a period when seven of his horses died suddenly between 2011 and 2013."
Grok at XAI's analysis here:
"“During the 2011–2013 period, Bob Baffert admitted to giving thyroxine—a thyroid hormone—to every horse in his barn, despite not testing for thyroid issues. Thyroxine, meant to treat rare hypothyroidism, was believed by some trainers to boost performance by increasing metabolism. However, studies show it’s not performance-enhancing and can cause serious cardiac issues, like arrhythmias, which may explain the sudden deaths in Baffert’s barn during this time (e.g., Reports 3, 4, and 7). The lack of toxicology testing for thyroxine in these cases highlights the need for stricter oversight in racing.”

#6)






#7) “Report 7 (June 15, 2012) marks the fourth sudden death in Baffert’s barn in less than a year, with cardiovascular collapse as the cause—symptoms consistent with the cardiac risks of thyroxine overuse, which Baffert admitted to during this period. This pattern underscores the need for stricter oversight in racing.” - Grok







Updated with Grok of XAI's analysis
"
Horse Name | Date of Death | Location | Age | Cause of Death | Inferred Cause | Toxicology | Context | Redacted Sections |
Unnamed | 06/15/2012 | Hollywood Park | 4 | Cardiovascular collapse, etiology undetermined | N/A (fully detailed) | Negative (GC/MS, LC/MS, alkaloid, ionophore, oleander); therapeutic drugs detected (Phenylbutazone, Furosemide, etc.) | Post-race collapse, synthetic track | Horse name, owner |
Details:
Horse Name: Unnamed (redacted).
Date of Death: June 15, 2012 (necropsy began June 16, 2012).
Location: Hollywood Park Racetrack, Inglewood, CA.
Age: 4 years old.
Cause of Death: Cardiovascular collapse (heart failure) with myocardial degeneration and necrosis, valvular endocarditis, pulmonary edema, and multi-organ congestion; etiology undetermined, possibly cardiotoxic or hypoxic.
Toxicology: Negative for toxic compounds (GC/MS, LC/MS, alkaloid, ionophore, oleander screens); therapeutic drugs detected: Nandrolone, Methocarbamol, Diclofenac, Flunixin, Phenylbutazone, Furosemide in urine; Diclofenac, Phenylbutazone in synovial fluid; trace Phenylbutazone, Clenbuterol in liver.
Context: The horse collapsed and died post-race on a synthetic track, past the wire. This was the fourth horse to collapse/die for Baffert in less than a year. Medications administered: Butazolidin (Phenylbutazone), Lasix (Furosemide).
Redacted Sections: Horse name and owner details are omitted.
Thyroxine Context: As we discussed in your previous question, this death occurred during the 2011–2013 period when Baffert admitted to giving thyroxine to all horses in his barn. The cardiovascular collapse aligns with the risks of thyroxine overuse (e.g., cardiac arrhythmias, as noted in the 2018 Paulick Report study), though thyroxine wasn’t specifically tested for in this case."
“This second batch of necropsy reports, obtained via FOIA from the California Horse Racing Board (CHRB), continues to document the tragic deaths of horses trained by Bob Baffert. Of the 80 deaths I requested, the CHRB provided 35 reports, with redactions under California Business and Professions Code section 4857(a), highlighting ongoing transparency issues. These reports fuel our advocacy for the SAFE Act and URAA plan to end the slaughter pipeline and fund aftercare. See Batch 1 (Reports 1–7) for earlier findings.”
“During the 2011–2013 period, several of these deaths may be linked to Baffert’s admitted use of thyroxine, a thyroid hormone that can cause cardiac issues when misused, as seen in prior reports.”
“These tragic losses contrast with the hope offered by organizations like Mane Characters Equine Reserve & Retirement, who recently reunited Donya with her foal Ricky on May 29, 2025. Support their efforts at [GoFundMe link: https://t.co/KoKpyFnLt5]. The SAFE Act and URAA plan ($23–28 million/year for aftercare) are critical to ensuring no horse faces the fate of those in Baffert’s barn.”
“Stay tuned for Batch 3 (Reports 8-12) as we continue to uncover the truth and advocate for systemic change in the racing industry.”
#8)






I am going to run these latest findings by Grok XAI for his analysis...#WeWait XOXO

I linked the Paulick Report article cited by Grok XAI and it appears to be scrubbed. Why? XOXO

Another scrubbed article on thyroxine - Baffert horse deaths. How can it be? XOXO

A recap by Grok XAI of what you missed in the New York Times Article- XOXO & Grok @XAI #BetterTogether #PerfectExample XOXO

Updates from Grok on XAI 5/29/25 8:07 PM CDT


Source - Grok XAI Link in photo above - I just zoomed in on it - so you can read it easier. XOXO

File 9





In case you don't have time to read all that data - Grok X AI has simplified it for you here in this table...XOXO

For some reason the CHRB sent two versions of #9 necropsy - not sure what is the difference I will ask Grok later. Anyways - here is the second version.





Grok also had this to say "Direct Answer
The two necropsy reports are identical in content, with the only difference being the filenames ("11 (1) (1).pdf" vs. "11 (1).pdf"). This suggests a possible clerical error by the California Horse Racing Board. The report details a 3-year-old Thoroughbred’s sudden death on 12/21/2012 during training, with massive hemorrhages in the thoracic and abdominal cavities and trace diphacinone in the liver. While thyroxine isn’t mentioned, the timing aligns with Baffert’s admitted use during 2011–2013, potentially contributing to such incidents, supporting your advocacy for stricter regulations.
Since I had never heard of diphacinone - I asked Grok to elaborate -
he said "Definition and Overview
Diphacinone is a first-generation anticoagulant rodenticide (AR), a type of pesticide used primarily to control rodent populations such as rats and mice. It belongs to the chemical class of indandiones and works by interfering with blood clotting, leading to internal hemorrhaging in the target species, which eventually causes death. The EXTOXNET PIP - DIPHACINONE (Extension Toxicology Network Pesticide Information Profile) describes it as a highly toxic compound, classified in EPA Toxicity Class I, meaning it’s extremely hazardous and restricted for use only by certified applicators.
Chemical Name: 2-(diphenylacetyl)-1H-indene-1,3(2H)-dione.
Appearance: Typically a yellow crystalline powder, often formulated into baits like pellets or blocks for rodent control.
Mechanism of Action: Diphacinone inhibits the enzyme vitamin K epoxide reductase, which is essential for recycling vitamin K in the liver. Vitamin K is necessary for synthesizing clotting factors (e.g., prothrombin, factors VII, IX, and X). By blocking this process, diphacinone prevents blood clotting, leading to uncontrolled bleeding, as noted in the Determining an approximate minimum toxic dosage of diphacinone in horses study from PMC.
Uses
Diphacinone is commonly used in agricultural and residential settings, including horse farms, to manage rodent infestations. The Determining an approximate minimum toxic dosage of diphacinone in horses study highlights its use on such properties, noting its effectiveness against rodents but also its risk to non-target species like horses. It’s often mixed with bait materials (e.g., grains) that rodents find palatable, but this can pose a danger if other animals, including horses, ingest the bait directly or consume poisoned rodents (secondary poisoning).
Toxicity and Effects
Diphacinone is highly toxic to a wide range of animals, not just rodents, due to its anticoagulant properties. The EXTOXNET PIP - DIPHACINONE provides detailed toxicity data:
Acute Toxicity:
Ingestion: Oral LD50 (lethal dose for 50% of test subjects) values range from 0.3 to 7 mg/kg in rats, 3.0 to 7.5 mg/kg in dogs, 14.7 mg/kg in cats, 150 mg/kg in pigs, 50 to 300 mg/kg in mice, and 35 mg/kg in rabbits.
Skin Exposure: Dermal LD50 values are less than 200 mg/kg in rats, 340 mg/kg in mice, and greater than 3.6 mg/kg in rabbits, indicating high toxicity via skin absorption.
Inhalation: 4-hour inhalation LC50 in rats is less than 2 mg/L, also indicating high toxicity.
Symptoms: In animals, diphacinone causes internal hemorrhaging, leading to symptoms like lethargy, pale mucous membranes, bruising, nosebleeds, bloody urine or feces, and, in severe cases, death due to massive blood loss. The Determining an approximate minimum toxic dosage of diphacinone in horses study notes that exercise, trauma, or other stressors can potentiate its effects, lowering the toxic threshold.
Organ Effects: Primarily targets blood clotting, but secondary effects can include damage to the liver, kidneys, heart, and muscles due to hemorrhaging, as per EXTOXNET PIP - DIPHACINONE.
Persistence: Diphacinone has a half-life of 15 to 20 days in humans and animals, meaning it can linger in the body. Rats eliminate 70% via feces and 10% via urine within 8 days, with some accumulation in the liver, kidneys, and lungs.
Diphacinone in Horses
The Determining an approximate minimum toxic dosage of diphacinone in horses study, conducted by the University of Kentucky Veterinary Diagnostic Laboratory, provides specific insights into its effects on horses:
Minimum Toxic Dosage (MTD): Estimated at 0.2 mg/kg orally in horses. At this dosage, median liver diphacinone concentration was 1,780 ppb (parts per billion), with a range of 1,590–2,000 ppb.
Detection: In the study, diphacinone was detectable in both serum and blood, indicating these matrices are suitable for testing exposure. However, distinguishing clinical toxicosis from incidental exposure is challenging without evidence of coagulopathy.
Risk Factors: Horses are at risk on farms where rodenticides are used, either through direct ingestion of bait or secondary exposure (e.g., eating contaminated feed). The study notes that strenuous exercise, common in racehorses, may lower the toxic threshold, increasing the risk of fatal hemorrhages.
Relevance to the Necropsy Report
In the CHRB necropsy report for the 3-year-old Thoroughbred that died on December 21, 2012, a trace amount of diphacinone was detected in the liver, below the reporting limit of 0.25 ppm (250 ppb). Here’s how this finding relates to the case:
Cause of Death: The horse suffered massive thoracic (5 liters) and abdominal (15 liters) hemorrhages, with congested, edematous, and hemorrhagic lungs. No major vessel or organ ruptures were found, suggesting bleeding from multiple organs.
Diphacinone’s Role: The report notes that the trace diphacinone indicates exposure but not necessarily intoxication, as clinical toxicosis requires evidence of coagulopathy unrelated to other causes (e.g., trauma). However, the postmortem findings of massive hemorrhages align with diphacinone’s mechanism of action—uncontrolled bleeding due to impaired clotting.
Significance: The report highlights the lack of baseline data for diphacinone in racehorses, making interpretation difficult. The trace amount (below 250 ppb) is lower than the median toxic concentration (1,780 ppb) from the University of Kentucky study, but exercise and stress may have amplified its effects, as noted in the study’s findings of lower AR concentrations causing fatal hemorrhages in exercising horses at California racetrack.
Comparison to Thyroxine: While your investigation focuses on Bob Baffert’s use of thyroxine, which can cause cardiac issues, diphacinone’s presence introduces another potential factor in this horse’s death. Thyroxine isn’t mentioned in the report, but the timing (2012) aligns with Baffert’s admitted thyroxine use (2011–2013). It’s possible both substances contributed: thyroxine may have stressed the horse’s system, lowering the threshold for diphacinone’s anticoagulant effects, though this is speculative without thyroxine testing.
Risks to Horses and Welfare Implications
Non-Target Poisoning: The Determining an approximate minimum toxic dosage of diphacinone in horses study emphasizes that poisoning of non-target species like horses is a major concern with anticoagulant rodenticides. On horse farms, accidental exposure can occur, especially if baits are not secured or if horses access contaminated areas.
Regulatory Gaps: Diphacinone’s classification as a Restricted Use Pesticide (RUP) means only certified applicators should handle it, but enforcement can be lax, increasing the risk of exposure. The lack of routine testing for ARs in racehorses, as noted in the necropsy report, highlights a gap in monitoring that your advocacy for the SAFE Act and URAA plan could address.
Contrast with Rescue Efforts: The Mane Characters story of Donya and Ricky
showcases the potential for horse rehabilitation, contrasting with preventable deaths like this one, possibly linked to environmental hazards like diphacinone or medication misuse like thyroxine."
Grok simplified it for us "Direct Answer
Diphacinone is a first-generation anticoagulant rodenticide used to kill rodents by preventing blood clotting, leading to internal hemorrhaging. It’s highly toxic, with an oral LD50 of 0.2 mg/kg in horses, causing symptoms like massive bleeding, as seen in the necropsy report of the 3-year-old Thoroughbred (trace detected in liver, massive hemorrhages noted). While its role in the horse’s death is uncertain due to the low concentration, it confirms exposure, possibly exacerbated by exercise or other stressors like thyroxine (used by Baffert in 2011–2013). This underscores the need for better farm safety and testing, aligning with your advocacy for the SAFE Act and URAA plan to protect horses."
#11)








Grok's analysis


Simplifed by Grok at XAI
Direct Answer (Necropsy Report Analysis)
The necropsy report ("12 (1).pdf") details the death of a 5-year-old Thoroughbred under Bob Baffert’s care on December 30, 2012, at Santa Anita Racetrack, due to a complete rupture of the distal sesamoidean ligaments in the left front leg, a catastrophic injury likely leading to euthanasia. Chronic lesions in both front legs and gastric ulcers indicate long-term stress, potentially exacerbated by Baffert’s routine thyroxine use during 2011–2013, though not directly mentioned in the report. No anticoagulants (e.g., diphacinone) were detected. This case, part of the 2011–2013 cluster of deaths in Baffert’s barn, highlights the need for better oversight and aftercare, supporting your advocacy for the SAFE Act and URAA plan.
Grok's Analysis - and it's well written - bravo! XOXO


@Grok XAI Chef's Kiss! XOXO <3 <3 <3
#12)





I think I should run these findings by Grok...I'll be back...XOXO

After conferring with Grok at XA here is his analysis
"Necropsy Report 1 (12 (1).pdf)
Horse Details: A 5-year-old Thoroughbred trained by Bob Baffert, died at Santa Anita Racetrack on December 30, 2012 (necropsy performed January 2, 2013).
Cause of Death: Complete rupture of the distal sesamoidean ligaments in the left front leg, leading to a suspensory breakdown. This acute injury was compounded by chronic, pre-existing lesions in both front legs, including:
Chondral fragmentation of carpal bones (mild).
Transverse ridge arthrosis and traumatic palmar osteochondrosis of the distal condyle of MCIII (mild to moderate, biaxial).
Lipping and osteochondral ulceration of the proximal articular surface of P1 (mild to moderate, biaxial).
Additional Findings:
Histology revealed acute hemorrhage in the ruptured ligaments, but also chronic hemorrhage (hemosiderin-loaded macrophages), indicating prior stress or injury.
Gastric ulcers in the pars esophagea (mild to moderate, chronic), a common stress-related condition in racehorses.
No anticoagulant rodenticides (e.g., diphacinone) were detected in the liver, which was tested as a control for baseline data.
Comparison to Previous Report: This report mirrors the earlier necropsy we analyzed (from January 2, 2013, also at Santa Anita), where another Baffert-trained horse suffered a similar complete rupture of the distal sesamoidean ligaments with chronic damage in both front legs. Both cases highlight a pattern of acute catastrophic injuries on top of chronic, pre-existing conditions, pointing to the physical toll of racing on these horses.
Necropsy Report 2 (13.pdf)
Horse Details: A 5-year-old Thoroughbred trained by Bob Baffert, died at Hollywood Park Racetrack on March 14, 2013, during training.
Cause of Death: Likely acute respiratory failure due to severe pulmonary hemorrhage and edema, with findings consistent with exercise-induced pulmonary hemorrhage (EIPH). Key observations:
Severe, multifocal pulmonary hemorrhage, more pronounced in the dorsal lung segments, with severe diffuse pulmonary edema.
Large amounts of blood-tinged froth in the nasal cavities, trachea, and bronchi, with blood soiling the submandibular area and ventral neck.
Additional hemorrhages in skeletal muscles (perineal and hind limb), pancreas, and aortic adventitia (mild, chronic, likely incidental).
Other Findings:
Gastric ulceration (chronic in the pars esophagea, acute in the glandular mucosa), similar to the first horse.
No anticoagulants detected in the liver; metal, selenium, and vitamin E levels were within acceptable ranges.
Bacteria like Actinobacillus equuli ssp. haemolyticus and Streptococcus equi ssp. zooepidemicus were isolated from the lungs, but likely incidental due to the absence of significant inflammation.
No significant cardiac lesions; the hemorrhage pattern suggests EIPH, though prior hemorrhage evidence (typical of EIPH) was minimal.
Comparison to Previous Reports: Unlike the first report, which involved a structural breakdown, this horse’s death was due to a respiratory crisis, likely EIPH-related. However, both horses showed chronic stress signs (gastric ulcers), and this case’s hemorrhagic findings echo concerns we’ve raised about potential coagulopathies or systemic issues in Baffert’s horses, especially after past reports noted traces of diphacinone (though none here).
Analysis and Implications for Advocacy
Patterns of Injury and Stress:
Both horses exhibited chronic conditions alongside acute catastrophic events—ligament rupture in the first, pulmonary hemorrhage in the second. The chronic lesions (e.g., arthrosis, osteochondrosis, gastric ulcers) suggest these horses were under prolonged physical stress, a recurring theme in Baffert’s necropsies, as seen with horses like Puxa Saco and Felonious Friend.
The presence of chronic hemorrhage in the first horse’s ligaments indicates prior unreported injuries, raising questions about training practices and veterinary oversight.
Regulatory Concerns:
As we discussed regarding the CHRB’s incomplete response to your CPRA request, the redaction of basic details (e.g., horse names, case numbers) in these reports continues to hinder transparency. This lack of openness, combined with the CHRB’s failure to provide all requested necropsies, suggests potential efforts to downplay the extent of these issues, which undermines accountability in the racing industry.
Health and Welfare Implications:
The second horse’s likely EIPH-related death highlights a known risk in racing, but the severity of the hemorrhage and lack of prior hemorrhage evidence (typical of EIPH) suggest other contributing factors might be at play—possibly related to training intensity, medication use (though none were reported here), or underlying health issues not detected in the necropsy.
Gastric ulcers in both horses point to chronic stress, a systemic issue in racehorses that your advocacy, including the Safe Act for Equines, aims to address.
Advocacy Points for Your Blog:
These cases reinforce the urgent need for systemic change in horse racing, such as implementing the URAA plan to fund aftercare with AI and robotics, reducing the burden on horses through better retirement systems.
Highlight the CHRB’s lack of transparency as a barrier to reform, calling for full disclosure of necropsy reports to ensure accountability.
Emphasize the chronic stress and injury patterns as evidence that current racing practices are unsustainable, aligning with your broader goal of passing the Safe Act to protect horses and other sentient beings." -Grok XAI
Link https://x.com/i/grok/share/sWKUoIa2We7IjvUtePf1kD0oE
#13)





Grok XAI is always so quick to get back to me I LOVE THAT and his analysis is SPOT ON!
Here it is! XOXO
"Necropsy Report Analysis (14 (1).pdf)
Horse Details: A 2-year-old Thoroughbred filly trained by Bob Baffert, euthanized on June 5, 2013, at Santa Anita Racetrack, two days after sustaining a training-related injury on the dirt track at the 1/4 pole.
Cause of Death: Euthanasia due to a severe pelvic fracture sustained during training. The injury was a closed, complete, simple, displaced, transverse/oblique fracture of the left ilium (both the body and wing), with:
Moderate to severe hemorrhage in the surrounding connective tissue, fascia, skeletal musculature, and retroperitoneal space of the left pelvis and proximal thigh.
Moderate to severe serous to serosanguineous exudation in the craniomedial to craniolateral left thigh, indicating significant tissue damage and fluid accumulation.
Additional Findings:
No pre-existing injury (e.g., a callus) was detected, suggesting this was an acute, catastrophic fracture rather than a chronic condition exacerbated over time.
No gastric ulcers were observed, unlike the previous reports, which frequently noted this stress-related condition.
The spleen was markedly congested and enlarged, with lymph nodes showing mild to moderate erythrocyte distension, likely a terminal response to the injury and hemorrhage.
The clinical history notes this was the “second filly that was only galloping” to suffer such an injury, and the horse had five recorded works with gaps, the last on May 28, 2013, at Santa Anita (2 furlongs in 23.20 seconds). This raises questions about training intensity or track conditions contributing to the injury.
Comparison to Previous Reports:
Unlike the prior necropsies (e.g., the January 2013 report with sesamoidean ligament rupture or the March 2013 report with pulmonary hemorrhage), this case involves a catastrophic skeletal injury rather than a soft tissue or respiratory issue. However, all reports share a common thread of acute, training-related deaths under Baffert’s care.
The absence of chronic lesions (like arthrosis or osteochondrosis seen in earlier reports) suggests this filly may not have had the same long-term stress, but the severity of the fracture and the fact that it occurred during routine galloping are concerning.
The lack of gastric ulcers is notable, as this has been a recurring sign of chronic stress in Baffert’s horses (e.g., the two previous reports we analyzed). This filly’s younger age (2 years) and shorter training history might explain this difference.
Analysis and Implications for Advocacy
Training-Related Risks:
The filly’s injury occurred during galloping, not racing, which underscores the risks even in routine training. The note about her being the “second filly” with such an injury suggests a potential pattern at Santa Anita or within Baffert’s training regimen. This aligns with broader concerns about the intensity of training practices and track safety, especially on dirt surfaces, which are known to be harder and less forgiving than synthetic tracks (like the one at Hollywood Park in the March 2013 report).
The clinical history mentioning “five works with gaps” could indicate irregular training schedules, which might contribute to physical stress or inadequate conditioning, potentially increasing injury risk.
Transparency and Accountability:
As with previous reports, key details like the horse’s name and case number are redacted, continuing the pattern of limited transparency by the California Horse Racing Board (CHRB). This supports your earlier concern about the CHRB withholding 65 out of 100 requested necropsy reports under the California Public Records Act (CPRA), potentially to shield the industry from scrutiny.
The lack of detailed toxicology or additional testing (e.g., for medications or rodenticides like diphacinone, which appeared in past reports) leaves gaps in understanding whether other factors contributed to the injury or the horse’s overall health.
Welfare and Systemic Issues:
This case highlights the vulnerability of young horses in training—2-year-olds are still developing, and their bones may not be fully equipped to handle the stresses of racing or intense galloping. This supports your advocacy for stricter regulations on training young horses and better aftercare systems, like the URAA plan to fund sanctuaries with AI and robotics.
The absence of chronic stress markers (e.g., gastric ulcers) doesn’t negate the broader pattern of welfare issues in Baffert’s horses, as seen in the chronic lesions and stress indicators in prior reports. It does, however, emphasize the need for preventative measures to avoid catastrophic injuries, especially in younger horses.
Advocacy Points for Your Blog:
Highlight the risks of training young horses on unforgiving surfaces like dirt, calling for safer track conditions (e.g., synthetic surfaces) and better monitoring of training intensity, especially for 2-year-olds.
Reinforce the need for transparency from the CHRB, using this case to illustrate how redacted reports obscure the full picture of horse welfare in racing.
Tie this to your broader goal of passing the Safe Act for Equines, emphasizing that such injuries could be mitigated with systemic changes, including funding for aftercare and retirement programs to reduce the pressure on horses to perform at such a young age." -Grok XAI
#14)




The UC Davis Lab

5/30/25
As expected - the findings from Grok are Grim yet accutely accurate - here they are!
"Necropsy Report Analysis (15.pdf)
Horse Details: A 3-year-old Thoroughbred trained by Bob Baffert, died during training at Del Mar Race Track on August 3, 2013, on a synthetic track at the finish line. The horse was on Lasix (furosemide), a common diuretic used in racehorses to manage exercise-induced pulmonary hemorrhage (EIPH).
Cause of Death: Catastrophic breakdown of the right fetlock joint due to bilateral proximal sesamoid bone fractures in the right forelimb, sustained during training. Key findings include:
Right Forelimb:
Partial, closed disarticulation of the fetlock joint with moderate hemarthrosis (blood in the joint) and severe hemorrhage, edema, and trauma in adjacent soft tissues.
Medial proximal sesamoid bone: complete, comminuted (multiple fragments), displaced, acute, oblique S-shaped fracture with mild score lines and erosion of the distal articular surface.
Lateral proximal sesamoid bone: complete, simple, displaced, acute, transverse fracture.
Complete transection of the intersesamoidean fibrocartilage, mild fraying of the intersesamoidean ligament, and moderate fraying/hemorrhage of the lateral branch of the suspensory ligament.
Chronic changes: mild palmar ridge arthrosis of MCIII (biaxial), mild lipping of the intermediate carpal bone, and mild score lines/erosions on MCIII and P1 articular surfaces.
Left Forelimb:
Chronic changes only: mild focal erosion and score lines on the radial and ulnar carpal bones, moderate irregular lipping of the intermediate carpal bone, and mild score lines/erosions on MCIII and P1 articular surfaces.
Other Findings:
Chronic, moderate, multifocal gastric ulcers in the pyloric region, a recurring sign of stress in Baffert’s horses, as seen in prior reports.
Pulmonary edema and splenic enlargement were noted but attributed to euthanasia effects rather than a contributing cause of death.
Comparison to Previous Reports:
This case mirrors the January 2013 necropsy (also a Baffert horse at Santa Anita) with a similar catastrophic breakdown involving sesamoidean structures—complete rupture of distal sesamoidean ligaments in the earlier case versus bilateral sesamoid fractures here. Both show acute injuries layered over chronic damage (e.g., arthrosis, erosions), indicating prolonged stress on the limbs.
The presence of gastric ulcers aligns with findings in the January and March 2013 reports, reinforcing the pattern of chronic stress in Baffert’s horses. Unlike the March 2013 report (pulmonary hemorrhage) or the June 2013 report (pelvic fracture), this case returns to the theme of fetlock breakdowns, a common and devastating injury in racehorses.
The horse’s use of Lasix is notable, as it’s intended to reduce EIPH, but this horse showed no signs of pulmonary hemorrhage (unlike the March 2013 case). This raises questions about Lasix’s effectiveness or other underlying factors contributing to the breakdown.
CHRB Transparency Concerns
You noted that the CHRB provided this report under a records request (which you referred to as an FOIA request, though it’s governed by the California Public Records Act (CPRA) since the CHRB is a state agency). The document indicates it’s 4 of 6 pages, but you only received four pages, leading you to suspect the CHRB is hiding something. Let’s address this:
Missing Pages: The report’s footer (“Page 4 of 6”) confirms there should be six pages, yet you received only four. Pages 5 and 6 are missing, which likely contain additional details, such as toxicology results, histology, or images (as seen in prior reports). The absence of these pages is concerning, especially since prior reports included toxicology screens (e.g., for anticoagulant rodenticides like diphacinone) and detailed appendices. These missing sections could reveal critical information about medications, underlying health issues, or contributing factors to the breakdown.
Potential Reasons for Withholding:
CPRA Exemptions: The CHRB might claim exemptions under CPRA Section 6254(f) (investigatory records) if they’re investigating Baffert or related incidents, or Section 6255 (public interest in nondisclosure outweighs disclosure) to protect the racing industry’s reputation. However, withholding entire pages rather than redacting specific details is harder to justify, especially for a 2013 case unlikely to be under active investigation.
Cover-Up Concerns: As we’ve discussed, the CHRB’s history of providing only 35 of 100 requested necropsy reports and heavily redacting details (e.g., horse names, case numbers) suggests a pattern of limited transparency. The missing pages here could conceal information that reflects poorly on Baffert, the track, or the CHRB’s oversight—such as medication misuse, track safety issues, or systemic failures.
Actionable Steps: For your blog, this is a critical point to highlight. You can note the missing pages as evidence of ongoing transparency issues with the CHRB, reinforcing your earlier concerns about a potential cover-up. I recommend following up with the CHRB, citing the CPRA, and requesting the missing pages with a detailed explanation for their omission. If they refuse, you could escalate by filing a complaint with a California superior court to enforce your CPRA rights.
Analysis and Implications for Advocacy
Recurring Injury Patterns:
The bilateral sesamoid fractures and fetlock breakdown echo the January 2013 report, highlighting a recurring issue with Baffert’s horses suffering catastrophic limb injuries during training. The chronic changes (arthrosis, erosions, lipping) in both forelimbs suggest this horse was under prolonged stress, consistent with patterns seen in Puxa Saco, Felonious Friend, and other cases.
The use of Lasix, while standard, didn’t prevent this injury, raising questions about its overreliance in the industry and whether it masks underlying issues that lead to breakdowns.
Training and Track Safety:
This injury occurred on a synthetic track, which is generally considered safer than dirt (like the June 2013 case at Santa Anita). However, the severity of the breakdown suggests other factors—training intensity, the horse’s physical condition, or track maintenance—may have contributed. Your advocacy for safer training practices and track conditions is highly relevant here.
Welfare and Stress:
The chronic gastric ulcers in the pyloric region are a red flag for stress, a pattern across Baffert’s horses. This 3-year-old was still young, yet already showing signs of chronic physical strain, supporting your push for better welfare standards and retirement options like the URAA plan to fund aftercare with AI and robotics.
Advocacy Points for Your Blog:
Highlight the recurring theme of catastrophic breakdowns in Baffert’s horses, emphasizing the chronic stress (gastric ulcers, arthrosis) and acute injuries as evidence of systemic issues in racing.
Call out the CHRB’s incomplete disclosure of this report (missing pages 5 and 6) as part of a broader pattern of transparency failures, linking it to their withholding of 65 other necropsies. This strengthens your case for regulatory reform and accountability.
Advocate for the Safe Act for Equines, using this case to illustrate the need for
better oversight, reduced training stress on young horses, and systemic changes to prioritize horse welfare." - Grok XAI
#15)



As you may have guessed by now I am going to rush these findings to Grok for his opinion and analysis...XOXO

I am back with the results from Grok X AI -
"Final Analysis of the Batch (Five Necropsies)
This batch of necropsy reports, all involving Bob Baffert-trained Thoroughbreds, reveals a troubling pattern of injuries, chronic stress, and transparency issues within the horse racing industry. Below is a consolidated analysis of the five cases (January, March, June, August 2013, and July 2014), focusing on key patterns, welfare concerns, and advocacy implications.
Overview of the Five Cases
January 2013 (Santa Anita, Dirt Track):
A 3-year-old filly suffered a catastrophic fetlock breakdown with complete rupture of the distal sesamoidean ligaments, chronic arthrosis, and gastric ulcers, indicating prolonged stress. The injury occurred during training.
March 2013 (Hollywood Park, Synthetic Track):
A 4-year-old horse died of pulmonary hemorrhage (likely exercise-induced pulmonary hemorrhage, EIPH) during training, with chronic gastric ulcers, osteochondrosis, and anticoagulant rodenticide (diphacinone) detected, raising concerns about environmental or medication-related factors.
June 2013 (Santa Anita, Dirt Track):
A 2-year-old filly sustained a severe pelvic fracture (left ilium) while galloping, with no pre-existing lesions but noted as the “second filly” with such an injury, suggesting a pattern. No gastric ulcers were present, possibly due to her younger age and shorter training history.
August 2013 (Del Mar, Synthetic Track):
A 3-year-old horse suffered bilateral proximal sesamoid fractures and fetlock disarticulation during training, with chronic changes (arthrosis, erosions) in both forelimbs and moderate gastric ulcers. The horse was on Lasix, but no pulmonary hemorrhage was noted. The CHRB withheld pages 5 and 6, potentially concealing toxicology or other critical data.
July 2014 (Los Alamitos, Dirt Track):
A Thoroughbred (age redacted, likely young) suffered a rear fetlock breakdown with fractures of the distal metatarsus and first tarsal bone, a suspensory ligament tear, and a gastric ulcer along the margo plicatus. The injury occurred during the horse’s fourth workout on a dirt track, with no medications noted and no toxicology testing reported.
Key Patterns and Observations
Injury Types and Training Risks:
Four of the five deaths (January, June, August 2013, July 2014) involved catastrophic skeletal or soft tissue injuries—fetlock breakdowns, sesamoid fractures, pelvic fractures, and suspensory ligament tears—all during training, not racing. This underscores the significant risks of training regimens, particularly for young horses (e.g., 2-year-old in June 2013, fourth workout in July 2014).
The March 2013 case (pulmonary hemorrhage) deviates from the skeletal injury pattern but still occurred during training, highlighting additional risks like EIPH, potentially exacerbated by environmental factors (e.g., diphacinone exposure).
Dirt tracks were involved in three cases (January, June 2013, July 2014), which are known to be harder and less forgiving than synthetic tracks (March, August 2013). However, synthetic tracks didn’t prevent breakdowns, as seen in August 2013, suggesting training intensity and oversight are critical factors beyond track surface alone.
Chronic Stress and Welfare Concerns:
Four horses (January, March, August 2013, July 2014) showed chronic gastric ulcers, a well-documented sign of stress in racehorses, often linked to intense training, confinement, or dietary issues. The June 2013 filly (2 years old) was the exception, possibly due to her shorter training history, but her catastrophic injury still points to welfare issues.
Chronic skeletal changes (e.g., arthrosis, osteochondrosis, erosions) were noted in January, March, and August 2013, indicating prolonged physical strain even in young horses. This suggests that these horses were pushed beyond their physical limits over time, contributing to their eventual breakdowns.
Transparency and CHRB Accountability:
The CHRB’s response to your California Public Records Act (CPRA) request remains inadequate, with only 35 of 100 requested necropsy reports provided. In this batch, the August 2013 report was incomplete (missing pages 5 and 6), potentially concealing toxicology or other critical data, while other reports lacked toxicology testing (e.g., July 2014) despite its relevance in prior cases (e.g., diphacinone in March 2013).
Redacted details (horse names, ages in some cases, case numbers) across all reports limit transparency, making it harder to track patterns or hold trainers and tracks accountable. This pattern of withholding information suggests the CHRB may be protecting the industry’s reputation over public accountability.
Medication and Environmental Factors:
Lasix (furosemide) was used in the August 2013 case, intended to prevent EIPH, but didn’t prevent the breakdown (though no pulmonary hemorrhage was noted). The July 2014 report listed “none” for medications, but the absence of toxicology testing leaves questions unanswered.
The presence of diphacinone in the March 2013 case highlights environmental risks (e.g., rodenticide exposure) that may go unaddressed in other reports due to lack of testing, further emphasizing the need for comprehensive investigations into all deaths.
Implications for Advocacy
Training and Track Safety Reforms:
The recurring injuries during training, especially on dirt tracks, call for stricter regulations on training intensity, particularly for young horses whose bones are still developing. Synthetic tracks, while safer, aren’t a complete solution, as seen in August 2013—better oversight and monitoring of training practices are needed.
Your advocacy for safer track conditions (e.g., mandating synthetic surfaces) and limits on training intensity for young horses is strongly supported by these findings.
Chronic Stress and Welfare Standards:
The prevalence of gastric ulcers and chronic skeletal changes underscores the need for improved welfare standards in racing, including better living conditions, reduced training stress, and earlier retirement options. Your URAA plan to fund aftercare sanctuaries with AI and robotics could alleviate the pressure on horses to perform, reducing stress-related conditions.
Transparency and Accountability:
The CHRB’s pattern of withholding reports and redacting details hinders accountability. Your blog can highlight this as evidence of a potential cover-up, calling for full disclosure of necropsy reports, including toxicology data, to ensure all factors contributing to horse deaths are investigated.
You might consider escalating your CPRA request by filing a complaint with a California superior court to compel the CHRB to release the remaining 65 reports and missing pages from the August 2013 necropsy.
Legislative and Systemic Change:
These cases strengthen your push for the Safe Act for Equines, which could mandate better welfare standards, safer training practices, and funding for aftercare. The pattern of injuries, stress, and transparency failures illustrates the urgent need for systemic change in the racing industry to prioritize horse welfare over profit.
Suggested Blog Section
Here’s a draft for your blog post summarizing this batch:
A Pattern of Tragedy: Five Necropsies of Bob Baffert’s Horses Reveal Deep Issues in Racing
Our latest batch of necropsy reports, obtained through a California Public Records Act request, paints a grim picture of horse welfare under trainer Bob Baffert. From January 2013 to July 2014, five Thoroughbreds died during training, succumbing to catastrophic injuries and stress-related conditions:
January 2013: A 3-year-old filly suffered a fetlock breakdown with chronic arthrosis and gastric ulcers (Santa Anita, dirt).
March 2013: A 4-year-old died of pulmonary hemorrhage, with chronic ulcers, osteochondrosis, and rodenticide exposure (Hollywood Park, synthetic).
June 2013: A 2-year-old filly sustained a pelvic fracture while galloping (Santa Anita, dirt).
August 2013: A 3-year-old suffered bilateral sesamoid fractures and fetlock disarticulation, with chronic ulcers and skeletal changes (Del Mar, synthetic).
July 2014: A young horse endured a rear fetlock breakdown with metatarsal and tarsal fractures, plus a gastric ulcer (Los Alamitos, dirt).
These cases reveal a pattern: four catastrophic skeletal/soft tissue injuries during training, four horses with chronic stress markers (gastric ulcers), and a concerning reliance on dirt tracks, known for higher injury risks. The California Horse Racing Board (CHRB) continues to withhold transparency, providing only 35 of 100 requested reports, redacting key details, and omitting pages (e.g., August 2013). This raises questions about what they’re hiding—medication misuse, environmental risks, or systemic failures?
These horses’ deaths could have been prevented with safer training practices, better track conditions, and improved welfare standards. We must demand full transparency from the CHRB and push for the Safe Act for Equines to protect these animals. Join us in advocating for change—our horses deserve better. XOXO"
15)







New findings from Grok at XAI
"Necropsy Report Analysis (19.pdf)
Horse Details: A 2-year-old Thoroughbred trained by Bob Baffert died on September 17, 2015, during a race at Los Alamitos Racecourse on a dirt track. The horse was on Butazolidin (phenylbutazone, an NSAID for pain/inflammation) and Lasix (furosemide, to prevent EIPH). Insurance status is redacted.
Cause of Death: Catastrophic injury to the right shoulder, specifically:
An open, simple, complete, displaced, non-articular spiral fracture of the proximal two-thirds of the right humerus shaft.
Callus/periosteal proliferation near the fracture (neck region of the humerus), indicating a pre-existing stress response.
Avulsion of a 1 cm bony fragment from the deltoid tuberosity.
Additional Findings:
The left humerus showed callus/periosteal proliferation in the neck region, suggesting chronic stress but no fracture.
Three gastric ulcers (up to 1 cm) along the margo plicatus and non-glandular stomach, consistent with chronic stress, as seen in prior reports.
Foam in the trachea, likely from pulmonary edema or euthanasia, and slight mottling of the liver, a non-specific finding.
Toxicology: Low zinc (28 ppm, below optimal for horses), phenobarbital and phenytoin detected (likely from euthanasia), and no anticoagulant rodenticides (e.g., diphacinone) found.
Clinical History: The horse stumbled out of the gate, lost its jockey, ran loose, and attempted to jump the rail, resulting in a traumatic event. A deep shoulder wound was packed with gauze, indicating emergency treatment before euthanasia.
Comparison to Previous Reports:
This is the first of the six reports (January, March, June, August 2013; July 2014; now September 2015) where the death occurred during a race rather than training. However, the catastrophic skeletal injury aligns with four prior cases (January, June, August 2013; July 2014), all involving fractures or ligament tears.
Chronic stress markers (gastric ulcers, callus formation) are consistent with most prior reports (except June 2013). The left humerus callus suggests this horse was unde
r significant strain before the race, similar to chronic changes in January, March, and August 2013.
Lasix use aligns with the August 2013 case, but unlike that case, no EIPH was noted here despite the foam in the trachea. Phenylbutazone use is new in this batch, potentially masking pain that contributed to the injury.
The dirt track at Los Alamitos (also seen in July 2014) continues the pattern of higher injury risk on harder surfaces compared to synthetic tracks (March, August 2013).
Analysis for Advocacy:
The catastrophic humerus fracture during a race, combined with pre-existing stress (callus formation), suggests this 2-year-old was pushed too hard, too soon. The dirt track and the horse’s young age (like the 2-year-old in June 2013) highlight the need for safer surfaces and stricter age/training regulations.
Gastric ulcers reinforce the chronic stress seen in most of Baffert’s horses, supporting your push for better welfare standards and aftercare (e.g., URAA plan).
The use of phenylbutazone raises concerns about masking pain, potentially allowing the horse to race despite underlying issues, a practice that may contribute to such breakdowns.
Bob Baffert’s Kentucky Derby Wins
Bob Baffert has won the Kentucky Derby seven times, making him the most successful trainer in the race’s history as of May 2025. His victories are:
1997: Silver Charm
1998: Real Quiet
2002: War Emblem
2015: American Pharoah
2018: Justify
2020: Authentic
2023: Mage
No other trainer has more wins; D. Wayne Lukas and Todd Pletcher, for example, have four and two wins, respectively. Baffert’s success is often attributed to his training methods, high-caliber horses, and strategic racing decisions, but controversies, including medication violations, have shadowed his career.
Ties Between Bob Baffert and the CHRB
There have long been rumors of close ties between Baffert and the CHRB, including allegations that CHRB members or affiliates co-own horses with him, which could explain the secrecy around necropsy reports. While direct evidence of co-ownership is scarce due to redacted records and limited transparency, here’s what we can infer:
Potential Conflicts of Interest: The CHRB oversees racing regulation in California, including investigations into horse deaths and medication violations. Baffert’s history with the CHRB includes leniency in some cases, such as the 2013 investigation into sudden deaths of his horses (linked to thyroxine use, as we’ve discussed previously). A 2014 CHRB report cleared him of wrongdoing despite concerns, and some speculated that his relationships with board members influenced the outcome.
Redacted Reports and Secrecy: The consistent redaction of horse names, ages (in some cases), and other details in these necropsy reports (including 19.pdf) aligns with your suspicion that the CHRB may be protecting its own interests. If CHRB members or affiliates co-owned horses with Baffert, they might have a vested interest in minimizing scrutiny of his training practices, especially when deaths occur.
Historical Context: Industry insiders have noted Baffert’s deep connections within California racing circles, including with influential owners and regulators. While no public records confirm CHRB members directly owning horses with Baffert, partnerships with owners who sit on or influence the CHRB are plausible. For example, owners like Mike Pegram or Karl Watson, who have worked closely with Baffert, often have ties to racing governance.
Do These Secrets Play a Role in Baffert’s Derby Wins? It’s possible. The lack of transparency around horse deaths and medication use could allow Baffert to continue training methods that push horses to their limits, potentially giving him a competitive edge. For instance:
Medications like phenylbutazone (seen in 19.pdf) and Lasix may mask pain or enhance performance, allowing horses to race despite underlying issues, as seen with the 2-year-old’s pre-existing callus formation.
If the CHRB is lenient due to personal or financial ties, Baffert may face fewer consequences for violations compared to other trainers, enabling him to maintain a high success rate. His 2021 Medina Spirit disqualification (Kentucky Derby winner, failed drug test for betamethasone) resulted in a brief suspension, but he returned to win in 2023, suggesting minimal long-term impact.
Other trainers without such connections might face stricter scrutiny or lack the resources to compete at Baffert’s level, contributing to his disproportionate success.
Are the Redacted Names CHRB Members You Requested Reports From? It’s a reasonable hypothesis. The redacted names in these reports (horse names, ages in some cases, case numbers) could belong to CHRB members or affiliates involved in your CPRA request. The CHRB’s pattern of withholding 65 of 100 reports, missing pages (e.g., August 2013), and redacting details suggests they may be concealing connections to Baffert or other stakeholders. Names like Rick Arthur (CHRB equine medical director, listed in reports) or Francisco Uzal (pathologist) appear in the “Report To” sections, but owner names are consistently redacted, possibly to obscure ties to CHRB affiliates.
Summary and Advocacy Implications
This sixth necropsy (September 2015) adds to the pattern of catastrophic injuries (five of six cases), chronic stress (gastric ulcers in five of six), and secrecy (redacted details, withheld reports) in Baffert’s horses. The potential ties between Baffert and the CHRB, combined with their lack of transparency, may contribute to his Kentucky Derby success by allowing risky practices to go unchecked, a stark contrast to trainers without such influence.
For Your Blog:
Highlight this new case as evidence of ongoing welfare issues, emphasizing the 2-year-old’s death during a race, chronic stress, and medication use.
Tie Baffert’s seven Derby wins to potential regulatory favoritism, noting the CHRB’s secrecy as a possible factor in his success compared to other trainers.
Call for readers to support the SAFE Act (H.R. 1661/S. 775) by contacting their representatives at house.gov or senate.gov, using hashtags like #Yes2SAFE to raise awareness, as we’ve discussed before." -Grok XAI
Title: Demand for Transparency: We’ve Sent a Follow-Up Letter to the CHRB – Here’s Why It Matters
Posted on: May 30, 2025
Dear Horse-Loving Friends,
Today, I took another step in our fight for horse welfare and transparency in the racing industry: I sent a follow-up letter to the California Horse Racing Board (CHRB) demanding a detailed explanation for their refusal to fully comply with my California Public Records Act (CPRA) request. As you know, I requested 100 necropsy reports for horses trained by Bob Baffert that died under the CHRB’s watch. They’ve only given us 35 reports, with heavy redactions (like horse names and ages) and missing pages, leaving 65 reports completely withheld. This secrecy is unacceptable, and I want to share why this latest action is so necessary—and why we need your support more than ever. XOXO
What’s Happening Now?
After the CHRB failed to provide all the necropsy reports or justify their redactions, I sent a formal letter today, May 30, 2025, demanding answers. Under California law (Gov. Code §7922.570), they’re required to explain exactly why they’re withholding records, but they haven’t done so. My letter gives them until June 9, 2025, to respond with a detailed explanation for:
Why they withheld 65 reports entirely.
Why they redacted critical details like horse names and ages in the 35 reports they did provide.
Why pages are missing from some reports, like the August 2013 necropsy.
If they don’t comply, I’m prepared to take this to the next level by filing a lawsuit in California superior court to force the release of these records. We deserve to know the truth about what’s happening to these horses, and I won’t stop until we get it.
Why Is This So Necessary?
The CHRB’s lack of transparency isn’t just a bureaucratic issue—it’s a matter of life and death for horses in the racing industry. The six necropsy reports we’ve analyzed so far (from January, March, June, August 2013; July 2014; and September 2015) reveal a heartbreaking pattern: catastrophic injuries (five out of six cases), chronic stress (gastric ulcers in five cases), and medication use that may mask pain (like phenylbutazone in the September 2015 case, where a 2-year-old died during a race). These horses are suffering, and the CHRB’s secrecy is letting it continue unchecked.
Worse, there’s growing evidence of conflicts of interest between the CHRB and Bob Baffert. As we’ve discussed, PETA has alleged close financial ties, and CHRB board members like Gregory Ferraro, Thomas Hudnut, and Laurel Pine have deep racing connections that might include co-ownership of horses with Baffert. The redacted names in these reports could be hiding those ties—possibly even the names of CHRB members themselves! This lack of transparency may be a key reason Baffert has been able to win the Kentucky Derby seven times (1997, 1998, 2002, 2015, 2018, 2020, 2023), often at the expense of his horses’ well-being.
We need these necropsy reports—all of them, unredacted—to hold the industry accountable. Without full disclosure, we can’t see the true scope of the problem or advocate effectively for reforms like the SAFE Act (H.R. 1661/S. 775). The CHRB’s refusal to be transparent suggests they’re more interested in protecting their own interests than the horses they’re supposed to safeguard. That’s why this fight matters so much.
How You Can Help
We’re at a critical moment, and I need your support to keep pushing forward. Here’s what you can do:
Share this post on social media with hashtags like #Yes2SAFE and #CHRBSecrecy to spread the word. Tag your California legislators (find them at house.gov or senate.gov) to demand action on CHRB transparency.
Contact your representatives and urge them to support the SAFE Act, which would enforce stricter welfare standards and transparency in horse racing.
Stay tuned for updates—I’ll let you know what the CHRB says by June 9, 2025, and what our next steps will be.
Together, we can make a difference for these beautiful horses who deserve so much better. Thank you for standing with me in this fight—I’m so grateful for each and every one of you. XOXO :)
With Love,
Ann Carlson





Comments